✦ LIBER ✦

Inhibition of multiple myeloma (MM) growth and preservation of bone with combined radiotherapy and anti-angiogenic agent

✍ Scribed by Dan Jia; Roopa Halakatti; Cassie Jackson; Larry Suva; Xin Li; Shmuel Yaccoby; Leah Hennings; Robert Griffin; Peter Corry

Book ID: 116320761
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 43
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2008.07.089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CEP-18770 (delanzomib) in combination wi

CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma

✍ Eric Sanchez; Mingjie Li; Jennifer Li; Cathy Wang; Haiming Chen; Susan Jones-Bol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Metronomic doxifluridine chemotherapy co

Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts

✍ Yasuko Naganuma; Batsuren Choijamts; Kyoko Shirota; Kyoko Nakajima; Shigenori Og 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Metronomic doxifluridine chemotherapy co

Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts

✍ Yasuko Naganuma; Batsuren Choijamts; Kyoko Shirota; Kyoko Nakajima; Shigenori Og 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

ResistantMicroascus cirrosus pneumonia c

ResistantMicroascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor

✍ Celalettin Ustun; Gerwin Huls; Marc Stewart; Kieren A. Marr 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 178 KB

The combination of intermediate doses of

The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma

✍ E. Hatjiharissi; E. Terpos; M. Papaioannou; C. Hatjileontis; V. Kaloutsi; G. Gal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

## Abstract The aim of the study was the evaluation of anti‐angiogenic activity of the combination of intermediate doses of thalidomide and dexamethasone in patients with refractory/relapsed myeloma. Twenty‐five patients were included in the study. Microvessel density (MVD) was evaluated in marrow